MedPath

湖南威特制药股份有限公司

Ownership
-
Established
2003-03-31
Employees
-
Market Cap
-
Website
www.weitezy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

NMPA:21

Drug Approvals

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20254357
Approval Date
May 27, 2025
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20254356
Approval Date
May 27, 2025
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20249762
Approval Date
Dec 17, 2024
NMPA

参芪阿胶颗粒

Approval Number
国药准字Z20090740
Approval Date
Mar 5, 2024
NMPA

伤科跌打片

Approval Number
国药准字Z20093418
Approval Date
Mar 5, 2024
NMPA

Omeprazole Enteric-coated Capsules

Product Name
奥美拉唑肠溶胶囊
Approval Number
国药准字H20143185
Approval Date
Feb 22, 2024
NMPA

暖宫孕子胶囊

Approval Number
国药准字Z20090224
Approval Date
Nov 16, 2023
NMPA

Hydrotalcite Granules

Product Name
铝碳酸镁颗粒
Approval Number
国药准字H20093294
Approval Date
Nov 16, 2023
NMPA

Nizatidine Dispersible Tablets

Product Name
尼扎替丁分散片
Approval Number
国药准字H20090065
Approval Date
Aug 3, 2023
NMPA

Paracetamol Chewable Tablets

Product Name
对乙酰氨基酚咀嚼片
Approval Number
国药准字H20084015
Approval Date
May 12, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.